首页> 外国专利> Process for Synthesis of (3S)- and (3R)-3-Hydroxy-Beta-Ionone, and Their Transformation to Zeaxanthin and Beta-Cryptoxanthin

Process for Synthesis of (3S)- and (3R)-3-Hydroxy-Beta-Ionone, and Their Transformation to Zeaxanthin and Beta-Cryptoxanthin

机译:(3S)-和(3R)-3-羟基-β-紫罗兰酮的合成方法及其向玉米黄质和β-隐黄质的转化

摘要

(3R)-3-Hydroxy-β-ionone and (3S)-3-hydroxy-β-ionone are two important intermediates in the synthesis of carotenoids with β-end group such as lutein, zeaxanthin, β-cryptoxanthin, and their stereoisomers. Among the various stereoisomers of these carotenoids, only (3R,3′R,6′R)-lutein, (3R,3′R)-zeaxanthin, and (3R)-β-cryptoxanthin are present in commonly consumed fruits and vegetables. There are 3 possible stereoisomers for zeaxanthin, these are: dietary (3R,3′R)-zeaxanthin (1), non-dietary (3S,3′S)-zeaxanthin (2), and non-dietary (3R,3′S;meso)-zeaxanthin (3) which is a presumed metabolite of dietary lutein. Dietary lutein as well as 1 and 3 are accumulated in the human macula and have been implicated in the prevention of age-related macular degeneration. (3R)-β-Cryptoxanthin (4) is also present in selected ocular tissues at a very low concentration whereas its enantiomer (3S)-β-cryptoxanthin (5) is absent in foods and human plasma.;The present invention relates to a process for the synthesis of (3R)-3-hydroxy-β-ionone and its (3S)-enantiomer in high optical purity from commercially available (rac)-α-ionone. The key intermediate for the synthesis of these hydroxyionones is 3-keto-α-ionone ketal that was prepared from (rac)-α-ionone after protection of this ketone as a 1,3-dioxolane. Reduction of 3-keto-α-ionone ketal followed by deprotection, lead to 3-hydroxy-α-ionone that was transformed into (rac)-3-hydroxy-β-ionone by base-catalyzed double bond isomerization in 46% overall yield from (rac)-α-ionone. The racemic mixture of these hydroxyionones was then resolved by enzyme-mediated acylation in 96% ee. (3R)-3-Hydroxy-β-ionone and its (3S)-enantiomer were respectively transformed to (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium chloride [(3R)—C15-Wittig salt] and its (3S)-enantiomer [(3S)—C15-Wittig salt] according to known procedures. Double Wittig condensation of these Wittig salts with commercially available 2,5-dimethylocta-2,4,6-triene-1,8-dial provided all 3 stereoisomers of zeaxanthin (1-3). Similarly, (3R)—C15-Wittig and its (3S)-enantiomer were each coupled with β-apo-12′-carotenal to yield 4 and 5.
机译:(3R)-3-羟基-β-紫罗兰酮和(3S)-3-羟基-β-紫罗兰酮是叶黄素,玉米黄质,β-隐黄质及其立体异构体等具有β端基类胡萝卜素合成的两个重要中间体。在这些类胡萝卜素的各种立体异构体中,通常食用的水果和蔬菜中仅存在(3R,3'R,6'R)-叶黄素,(3R,3'R)-玉米黄质和(3R)-β-隐黄质。玉米黄质有3种可能的立体异构体,分别是:膳食(3R,3'R)-玉米黄质(1),非饮食(3S,3'S)-玉米黄质(2)和非饮食(3R,3' S; meso)-玉米黄质(3),是膳食叶黄素的推测代谢产物。饮食中的叶黄素以及1和3积累在人的黄斑中,与预防与年龄有关的黄斑变性有关。 (3R)-β-隐黄质(4)也以非常低的浓度存在于选定的眼组织中,而食品和人血浆中不存在其对映体(3S)-β-隐黄质(5)。由市售(rac)-α-紫罗兰酮合成高光学纯度的(3R)-3-羟基-β-紫罗兰酮及其(3S)-对映体的方法。合成这些羟基酮的关键中间体是3-酮基-α-紫罗兰酮缩酮,该酮是在将酮保护为1,3-二氧戊环后由(rac)-α-紫罗兰酮制备的。还原3-酮-α-紫罗兰酮缩酮,然后脱保护,导致3-羟基-α-紫罗兰酮通过碱催化的双键异构化转化为(rac)-3-羟基-β-紫罗兰酮,总产率为46%来自(rac)-α-紫罗兰酮。然后通过酶介导的酰化作用将这些羟基酮的外消旋混合物溶于96%ee。将(3R)-3-羟基-β-紫罗兰酮及其(3S)-对映体分别转化为(3R)-3-羟基-(β-亚萘基乙基)三苯基phenyl氯化物[(3R)-C 15 -Wittig盐]及其(3S)-对映体[(3S)-C 15 -Wittig盐]。这些维蒂希盐与可商购的2,5-二甲基辛基-2,4,6-三烯-1,8-丁二酯的双重维蒂希缩合提供了玉米黄质的所有3种立体异构体(1-3)。同样,(3R)-C 15 -Wittig及其(3S)-对映异构体分别与β-apo-12'-胡萝卜素偶联,生成4和5。

著录项

  • 公开/公告号US2009311761A1

    专利类型

  • 公开/公告日2009-12-17

    原文格式PDF

  • 申请/专利权人 FREDERICK KHACHIK;AN-NI CHANG;

    申请/专利号US20090484703

  • 发明设计人 FREDERICK KHACHIK;AN-NI CHANG;

    申请日2009-06-15

  • 分类号C12P7/26;C07C45/67;

  • 国家 US

  • 入库时间 2022-08-21 18:53:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号